BKD three-lens brief
Evidence-based stock research on BKD. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
50-day MA below 200-day MA (death-cross regime); price below both. · Trading at 5% of its 52-week range — deep in the lower band.
- Trading at 5% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- Underperforming SPY by 14.5pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $16.17 — 75% above current (6 analysts).
BKD closed at $9.22 (-1.71%) as of 2026-11-12. Market cap: $2.21B. Price is below the 50-day MA and below the 200-day MA. Positives: analyst mean target $16.17 — 75% above current (6 analysts).. Concerns: trading at 5% of its 52-week range — deep in the lower band.; 50-day MA below 200-day MA (death-cross regime); price below both.. Last quarter: Revenue $712.07M, net income -$13.91M, free cash flow -$108.71M.
Why three lenses on BKD, not one.
A single reasoning model has blind spots it doesn’t know about. We examine BKD across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/BKD" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath BKD brief"></iframe>